Skip to content
★ Sign in to follow
MF

Marshman Fund Trust II

Related company / holding
Total declarations
5
Company
1
▲ Purchases (1 ops.)
€6.9M
▼ Sales (2 ops.)
€128.1M

Latest filing published 05 Nov 2024 for Harmony Biosciences Holdings, Inc., €16.7M.

Filing timeline

BuySale
Marshman Fund Trust II

Insider track record

Disclosed buys
1
Disclosed sells
2
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Marshman Fund Trust II: trading record in brief

All filings by Marshman Fund Trust II on record concern Harmony Biosciences Holdings, Inc. Between 21 August 2020 and 5 November 2024, the trades on record add up to 5 filings.

In open-market terms, that means 1 purchase worth €6.9M on one side and 2 sales worth €128.1M on the other. On balance, insiders were net sellers of €121.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2024 alone, the filings show no purchases and 2 sales.

The newest entry dates from 5 November 2024: an open-market sale of €16.7M, in Harmony Biosciences Holdings, Inc. The clock since the last published purchase (16 October 2020) now reads 2,214 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Marshman Fund Trust II

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total

5 of 4 declarations